The relevance of IRFs in CLL is supported by the observation that the high expression of several IRFs (IRF2, IRF5 and IRF6) in B-CLL patient cells is associated with poor survival outcome (Log-rank test (LRT) < 0.015) (Fig. 4D). This evidence concerns the gene IRF2 and B-cell chronic lymphocytic leukemia.